In patients with allergic rhinitis, intranasal budesonide lowers type 2 and neutrophilic marker levels, improves airflow, and ...
Severe exacerbation occurred in 5.1% of patients taking albuterol/budesonide compared with 9.1% of patients taking albuterol alone in the on-treatment efficacy population. Albuterol/budesonide ...
Budesonide is a synthetic steroid with a 15-fold higher affinity for glucocorticoid receptors. It is an alternative to prednisolone. Due to its high first-pass metabolism in the liver, budesonide ...
The researchers evaluated budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol in preventing COPD exacerbations and pneumonia hospitalizations in real-world settings. They ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results